Coronavirus: Global cases surpass five million

Latin America accounted for around a third of the cases reported earlier this week

The intensive care unit treating  coronavirus patients in the Gilberto Novaes Hospital in Manaus, Brazil. Brazil has seen a record number of coronavirus deaths this week. Photograph: Michael Dantas/AFP via Getty
The intensive care unit treating coronavirus patients in the Gilberto Novaes Hospital in Manaus, Brazil. Brazil has seen a record number of coronavirus deaths this week. Photograph: Michael Dantas/AFP via Getty

Global coronavirus cases surpassed five million on Wednesday, with Latin America overtaking the United States and Europe in the past week to report the largest portion of new daily cases globally.

It represents a new phase in the virus’ spread, which initially peaked in China in February, before large-scale outbreaks followed in Europe and the United States.

Latin America accounted for around a third of the 91,000 cases reported earlier this week. Europe and the United States each accounted for just over 20 per cent.

A large number of those new cases came from Brazil, which recently surpassed Germany, France and the UK to become the third-largest outbreak in the world, behind the US and Russia.

READ MORE

Cases in Brazil are now rising at a daily pace second only to the US.

At more than five million cases, the virus has infected more people in under six months than the annual total of severe flu cases, which the World Health Organisation (WHO) estimates is around three million to five million globally.

The pandemic has claimed over 326,000 lives, though the true number is thought to be higher as testing is still limited and many countries do not include fatalities outside of hospitals. Over half of the total fatalities have been recorded in Europe.

Despite the continued increase in cases, many countries are opening schools and workplaces following weeks of lockdown that have stemmed the spread.

Financial markets have also been boosted slightly by promising early results from the first US vaccine trial in humans. – Reuters